{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:14:34Z","timestamp":1761016474542},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1007\/bf02251285","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T13:43:55Z","timestamp":1132062235000},"page":"302-308","source":"Crossref","is-referenced-by-count":53,"title":["Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients"],"prefix":"10.1007","volume":"110","author":[{"given":"Sebastian","family":"H\u00e4rtter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Wetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02251285_CR1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/ajp.146.7.911","volume":"146","author":"RB Aranow","year":"1989","unstructured":"Aranow RB, Hudson JI, Pope HG jr, Grady TA, Laage TA, Bell IR, Cole JO (1989) Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry 146:911\u2013913","journal-title":"Am J Psychiatry"},{"issue":"Suppl 232","key":"BF02251285_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/acta.0.0930001-b","volume":"93","author":"P Ball","year":"1980","unstructured":"Ball P, Knuppen R (1980) Catecholestrogens (2- and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol 93 [Suppl 232]:1\u2013127","journal-title":"Acta Endocrinol"},{"key":"BF02251285_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000416218","volume":"17","author":"P Bech","year":"1988","unstructured":"Bech P (1988) A review of the antidepressant properties of serotonin reuptake inhibitor. Adv Biol Psychiatry 17:58\u201369","journal-title":"Adv Biol Psychiatry"},{"key":"BF02251285_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-198632040-00002","volume":"32","author":"P Benfield","year":"1986","unstructured":"Benfield P, Ward A (1986) Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:313\u2013334","journal-title":"Drugs"},{"key":"BF02251285_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00315151","volume":"40","author":"G Bertschy","year":"1991","unstructured":"Bertschy G, Vandel S, Vandel B, Allers G, Volmat R (1991) Fluvoxamine-tricyclic antidepressant interaction. An accidental finding. Eur J Clin Pharmacol 40:119\u2013120","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02251285_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-1017223","volume":"4","author":"E Boll","year":"1986","unstructured":"Boll E, Tarighati MA, Holsboer F (1986) Clinical application of antidepressant plasma level analysis with high pressure liquid chromatography (HPLC). Pharmacopsychiatry 4:257\u2013258","journal-title":"Pharmacopsychiatry"},{"key":"BF02251285_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.1991.tb05630.x","volume":"32","author":"K Br\u00f8sen","year":"1991","unstructured":"Br\u00f8sen K, Skjelbo E (1991) Fluoxetine and norfluoxetine are potent inhibitors of P450IID6\u2014the source of the sparteine\/debrisoquine oxidation polymorphism. Br J Clin Pharmacol 32:136\u2013137","journal-title":"Br J Clin Pharmacol"},{"key":"BF02251285_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/clpt.1986.221","volume":"40","author":"K Br\u00f8sen","year":"1986","unstructured":"Br\u00f8sen K, Otten V, Gram LF (1986) Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype. Clin Pharmacol Ther 40:543\u2013549","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 3","key":"BF02251285_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2165\/00003495-199000403-00010","volume":"40","author":"RK Chawla","year":"1990","unstructured":"Chawla RK, Bonkovsky HL, Galambos JT (1990) Biochemistry and pharmacology of S-adenosyl-l-methionine and rationale for its use in liver disease. Drugs 40 [Suppl 3]:98\u2013110","journal-title":"Drugs"},{"key":"BF02251285_CR10","doi-asserted-by":"crossref","first-page":"349S","DOI":"10.1111\/j.1365-2125.1983.tb02125.x","volume":"15","author":"V Claasen","year":"1983","unstructured":"Claasen V (1983) Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Clin Pharmacol 15:349S-355S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02251285_CR11","first-page":"391","volume":"8","author":"S Clarke","year":"1983","unstructured":"Clarke S, O'Connor CM (1983) Do eukaryotic carboxyl methyltransferases regulate protein function? TIBS 8:391\u2013394","journal-title":"TIBS"},{"issue":"Suppl 3","key":"BF02251285_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/S000712500029733X","volume":"153","author":"GL Cooper","year":"1988","unstructured":"Cooper GL (1988) The safety of fluoxetine \u2014 an update. Br J Psychiatry 153 [Suppl 3]:77\u201386","journal-title":"Br J Psychiatry"},{"key":"BF02251285_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003495-199141020-00007","volume":"41","author":"KL Dechant","year":"1991","unstructured":"Dechant KL, Clissold SP (1991) Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41:225\u2013253","journal-title":"Drugs"},{"key":"BF02251285_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1600-0447.1991.tb03200.x","volume":"84","author":"J Fritze","year":"1991","unstructured":"Fritze, J, Unsorg B, Lanczik M (1991) Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand 84:583\u2013584","journal-title":"Acta Psychiatr Scand"},{"key":"BF02251285_CR15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.148.6.790","volume":"148","author":"DC Goff","year":"1991","unstructured":"Goff DC, Midha KK, Brotman AW, Waites M, Baldessarini RJ (1991) Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. Am J Psychiatry 148:790\u2013792","journal-title":"Am J Psychiatry"},{"key":"BF02251285_CR16","series-title":"Psychopharmacology Series","first-page":"184","volume-title":"Clinical pharmacology in psychiatry. Selectivity in psychotropic drug action-promises or problems?","author":"LF Gram","year":"1987","unstructured":"Gram LF, Br\u00f8sen K, Christensen P, Kragh-Sorensen P (1987) Pharmacokinetic considerations relevant to the pharmacodynamics of antidepressants. In: Dahl SG, Gram LF, Paul SM, Potter WZ (eds) Clinical pharmacology in psychiatry. Selectivity in psychotropic drug action-promises or problems? Psychopharmacology Series 3. Springer, Berlin Heidelberg New York, pp 184\u2013192"},{"key":"BF02251285_CR17","doi-asserted-by":"crossref","unstructured":"H\u00e4rtter S, Wetzel, H, Hiemke C (1992) Automated determination of fluvoxamine in human plasma by column switching-high performance liquid chromatography. Clin Chem (in press)","DOI":"10.1093\/clinchem\/38.10.2082"},{"key":"BF02251285_CR18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0006-2952(64)90196-0","volume":"13","author":"JF Henderson","year":"1964","unstructured":"Henderson JF, Mazel P (1964) Studies of the induction of microsomal S-, N- and O-demethylases. Biochem Pharmacol 13:1471\u20131474","journal-title":"Biochem Pharmacol"},{"key":"BF02251285_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF00178516","volume":"88","author":"R Kr\u00fcger","year":"1986","unstructured":"Kr\u00fcger R, H\u00f6lzl G, Kuss HJ, Schefold L (1986) Comparison of the metabolism of the three antidepressants amitriptyline, imipramine, and chlorimipramine in vitro in rat liver microsomes. Psychopharmacology 88:505\u2013513","journal-title":"Psychopharmacology"},{"key":"BF02251285_CR20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2165\/00003495-199141030-00008","volume":"41","author":"RJ Milne","year":"1991","unstructured":"Milne RJ, Goa KL (1991) Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41:450\u2013477","journal-title":"Drugs"},{"key":"BF02251285_CR21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archpsyc.1991.01810280019002","volume":"48","author":"JC Nelson","year":"1991","unstructured":"Nelson JC, Mazure CM, Bowers MB, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48:303\u2013307","journal-title":"Arch Gen Psychiatry"},{"key":"BF02251285_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199108293250907","volume":"325","author":"WZ Potter","year":"1991","unstructured":"Potter WZ, Rudorfer MV, Maji H (1991) The pharmacologic treatment of depression. N Engl J Med 325:633\u2013642","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"BF02251285_CR23","first-page":"9","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E (1990) Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 51 [Suppl B]:9\u201312","journal-title":"J Clin Psychiatry"},{"key":"BF02251285_CR24","first-page":"807","volume":"148","author":"DL Rosenstein","year":"1991","unstructured":"Rosenstein DL, Takeshita J, Nelson JC (1991) Fluoxetine-induced elevation and prolongation of tricyclic levels in overdose. Am J Psychiatry 148:807","journal-title":"Am J Psychiatry"},{"key":"BF02251285_CR25","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1097\/00004714-198712001-00005","volume":"7","author":"AF Schatzberg","year":"1987","unstructured":"Schatzberg AF, Dessain E, O'Neil P, Katz DL, Cole JO (1987) Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine,\/and fluvoxamine, J Clin Psychopharmacol 7:44S-49S","journal-title":"J Clin Psychopharmacol"},{"key":"BF02251285_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00004714-198812000-00004","volume":"8","author":"LS Schneider","year":"1988","unstructured":"Schneider LS, Cooper TB, Severson JA, Zemplenyi T, Sloane RB (1988) Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. J Clin Psychopharmacol 8:402\u2013408","journal-title":"J Clin Psychopharmacol"},{"key":"BF02251285_CR27","first-page":"359","volume-title":"Frontiers in biochemical and pharmacological research in depression","author":"F Sj\u00f6qvist","year":"1984","unstructured":"Sj\u00f6qvist F, Bertilsson L (1984) Clinical pharmacology of antidepressant drugs: pharmacogenetics. In: Usdin E et al (eds) Frontiers in biochemical and pharmacological research in depression. Raven Press, New York, pp 359\u2013371"},{"key":"BF02251285_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/288277a0","volume":"288","author":"DE Vance","year":"1980","unstructured":"Vance DE, de Kuijff B (1980) The possible functional significance of phosphatidylethanolamine methylation. Nature 288:277\u2013279","journal-title":"Nature"},{"key":"BF02251285_CR29","unstructured":"Vandel S, Bouquet S, Bonin B, Bertschy G, Baumann P (1991) Pharmacokinetics of antidepressants: fluoxetine and fluvoxamine in daily clinical practice. In: Racagni G et al (eds) Biological psychiatry. Elsevier Amsterdam, pp 368\u2013371"},{"key":"BF02251285_CR30","first-page":"1478","volume":"145","author":"DA Vaughan","year":"1988","unstructured":"Vaughan DA (1988) Interaction of fluoxetine with tricyclic antidepressant (letter). Am J Psychiatry 145:1478","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02251285\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:22:00Z","timestamp":1586560920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02251285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["BF02251285"],"URL":"https:\/\/doi.org\/10.1007\/bf02251285","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2]]}}}